---
created: 2025-04-13
updated: 2025-04-13T10:52
id: pQ{whs*>)|
specialty: gastro
specialty_id: 287
tags:
  - source/ak-original-decks::step-1::zanki-step-decks::zanki-gi::gi-pathology
  - source/ak-step1-v11::!flag-these-cards::sketchypathadds
  - source/ak-step1-v11::
  - theme/firstaid::09-gastrointestinal::04-pathology::46-cholangiocarcinoma
  - source/ak-step1-v11::
  - theme/ome::11-gastrointestinal::03-hepatobiliary::03-cholestasis
  - source/ak-step1-v11::
  - source/ome-banner
  - source/ak-step1-v11::
  - theme/sketchypath::06-hepatobiliary::01-gallbladder-&-biliary-tract-disease::03-autoimmune-biliary-tract-disorders-&-cancer
  - source/ak-step1-v11::
  - theme/uworld::10000-99999::16000-16999::16107
  - source/ak-step1-v11::^other::^expn::jbadd
  - source/ak-step1-v11::^other::^highyield::4-loweryield
  - source/ak-step1-v11::^systems::gi::jbadds"
type: flashcard
---

# Question
Cholangiocarcinoma is an adenocarcinoma of bile duct epithelium that is diagnosed with **ERCP + biopsy** = cholestatic pattern of liver injury (elevated ALP, hyperbilirubinemia), weight loss, RUQ pain, jaundice, and hepatomegaly  * Bonus: What's the characteristic Histology pattern?

---

# Answer
* ERCP allows for direct visualization of the lesion location, bile duct scrapings or biopsy for defining diagnosis, and stenting of any associated occlusion   * Treatment includes surgical resection and chemotherapy; however, the condition is often late-stage or terminal at the time of diagnosis